$NVOS
Novo Integrated Sciences, Inc. Stock $nvos

$nvos Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000149315224014632 Filed on April 15, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$3.152M	$3.171M	$2.557M
YoY Change	-4.28%	24.02%	-10.9%
Cost Of Revenue	$2.255M	$1.847M	$1.586M
YoY Change	13.95%	16.45%	-4.07%
Gross Profit	$896.9K	$1.324M	$970.9K
YoY Change	-31.75%	36.38%	-20.18%
Gross Profit Margin	28.46%	41.76%	37.98%
Selling, General & Admin	$3.417M	$2.864M	$2.758M
YoY Change	24.51%	3.85%	-17.36%
% of Gross Profit	380.99%	216.29%	284.04%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$556.7K	$568.2K	$552.6K
YoY Change	-3.95%	2.82%	-28.56%
% of Gross Profit	62.07%	42.91%	56.92%
Operating Expenses	$3.417M	$2.864M	$2.758M
YoY Change	24.51%	3.85%	-17.36%
Operating Profit	-$2.520M	-$1.540M	-$1.787M
YoY Change	76.19%	-13.83%	-15.74%
Interest Expense	$178.4K	-$897.0K	$123.9K
YoY Change	-425.15%	-824.19%	-104.51%
% of Operating Profit
Other Income/Expense, Net	-$11.22M	-$308.8K	-$2.858M
YoY Change	20338.61%	-89.2%	4.03%
Pretax Income	-$13.74M	-$2.746M	-$4.645M
YoY Change	824.82%	-40.89%	-4.58%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$13.74M	-$2.746M	-$4.621M
YoY Change	817.76%	-40.58%	-5.07%
Net Earnings / Revenue	-435.99%	-86.61%	-180.77%
Basic Earnings Per Share	-$0.74	-$0.16	-$0.06
Diluted Earnings Per Share	-$0.74	-$0.16	-$0.06
COMMON SHARES
Basic Shares Outstanding	19.05M shares	17.75M shares	144.3M shares
Diluted Shares Outstanding	18.69M shares	17.64M shares	7.933M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.540M	$651.8K	$609.7K
YoY Change	231.84%	6.89%	-96.18%
Cash & Equivalents	$1.540M	$651.8K	$609.7K
Short-Term Investments
Other Short-Term Assets	$214.4K	$217.6K	$546.6K
YoY Change	-3.15%	-60.19%	8.57%
Inventory	$1.112M	$947.4K	$925.1K
Prepaid Expenses
Receivables	$2.252M	$2.154M	$923.6K
Other Receivables	$1.043M	$1.049M	$1.046M
Total Short-Term Assets	$6.161M	$5.019M	$4.051M
YoY Change	54.11%	23.91%	-78.7%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.158M	$7.163M	$5.449M
YoY Change	-31.3%	31.45%	-35.94%
Goodwill	$7.524M	$7.561M	$7.539M
YoY Change	-0.25%	0.28%
Intangibles	$14.69M	$15.21M	$17.20M
YoY Change	-12.02%	-11.59%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$29.17M	$29.93M	$32.44M
YoY Change	-8.13%	-7.73%	-36.77%
TOTAL ASSETS
Total Short-Term Assets	$6.161M	$5.019M	$4.051M
Total Long-Term Assets	$29.17M	$29.93M	$32.44M
Total Assets	$35.33M	$34.95M	$36.49M
YoY Change	-1.17%	-4.22%	-48.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.895M	$2.174M	$2.040M
YoY Change	105.41%	6.55%	84.5%
Accrued Expenses	$1.332M	$2.224M	$1.223M
YoY Change	-30.69%	81.84%	-47.66%
Deferred Revenue			$35.44K
YoY Change
Short-Term Debt	$1.487M	$2.208M	$890.2K
YoY Change	40.52%	147.97%	-56.48%
Long-Term Debt Due	$1.008M	$1.014M	$1.020M
YoY Change	-18.65%	-0.6%	-80.68%
Total Short-Term Liabilities	$22.68M	$9.959M	$6.178M
YoY Change	265.24%	61.2%	-46.53%
LONG-TERM LIABILITIES
Long-Term Debt	$63.57K	$64.02K	$64.98K
YoY Change	-2.12%	-1.48%	-99.4%
Other Long-Term Liabilities	$1.534M	$1.639M	$1.891M
YoY Change	-14.15%	-13.29%	1.27%
Total Long-Term Liabilities	$1.598M	$1.703M	$1.956M
YoY Change	-13.73%	-12.9%	-84.67%
TOTAL LIABILITIES
Total Short-Term Liabilities	$22.68M	$9.959M	$6.178M
Total Long-Term Liabilities	$1.598M	$1.703M	$1.956M
Total Liabilities	$25.66M	$12.76M	$9.526M
YoY Change	179.61%	33.95%	-63.03%
SHAREHOLDERS EQUITY
Retained Earnings	-$88.20M	-$74.46M	-$62.38M
YoY Change	38.09%	19.37%
Common Stock	$19.06K	$17.75K	$139.6K
YoY Change	-86.85%	-87.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$9.956M	$22.19M	$27.25M
YoY Change
Total Liabilities & Shareholders Equity	$35.33M	$34.95M	$36.49M
YoY Change	-1.17%	-4.22%	-48.11%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$13.74M	-$2.746M	-$4.621M
YoY Change	817.76%	-40.58%	-5.07%
Depreciation, Depletion And Amortization	$556.7K	$568.2K	$552.6K
YoY Change	-3.95%	2.82%	-28.56%
Cash From Operating Activities	-$658.0K	-$1.714M	-$878.6K
YoY Change	-23.29%	95.04%	-60.96%
INVESTING ACTIVITIES
Capital Expenditures	$2.010K		$0.00
YoY Change	-89.35%		-100.0%
Acquisitions
YoY Change
Other Investing Activities			$0.00
YoY Change
Cash From Investing Activities	-$2.010K		$0.00
YoY Change	-89.35%		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.820M	3.190K	429.3K
YoY Change	101.95%	-99.26%	-95.45%
NET CHANGE
Cash From Operating Activities	-658.0K	-1.714M	-878.6K
Cash From Investing Activities	-2.010K		0.000
Cash From Financing Activities	1.820M	3.190K	429.3K
Net Change In Cash	1.160M	-1.710M	-449.3K
YoY Change	4644.76%	280.71%	-106.31%
FREE CASH FLOW
Cash From Operating Activities	-$658.0K	-$1.714M	-$878.6K
Capital Expenditures	$2.010K		$0.00
Free Cash Flow	-$660.0K		-$878.6K
YoY Change	-24.71%		-59.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--08-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001138978
CY2023Q3	us-gaap	Derivative Liabilities DerivativeLiabilities		usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q4	NVOS	Stock Issued During Period Value To Be Issued StockIssuedDuringPeriodValueToBeIssued		usd
CY2023Q4	NVOS	Stock Issued During Period Value Stock Splits StockIssuedDuringPeriodValueStockSplits		usd
CY2022Q4	NVOS	Stock Issued During Period Value To Be Issued StockIssuedDuringPeriodValueToBeIssued		usd
CY2023Q1	NVOS	Stock Issued During Period Value To Be Issued StockIssuedDuringPeriodValueToBeIssued		usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	NVOS	Debt Discount Recognized On Derivative Liability DebtDiscountRecognizedOnDerivativeLiability		usd
	NVOS	Debt Discount Recognized On Convertible Note DebtDiscountRecognizedOnConvertibleNote		usd
	NVOS	Extinguishment Of Derivative Liability Due To Conversions ExtinguishmentOfDerivativeLiabilityDueToConversions		usd
	NVOS	Common Stock Issued With Convertible Notes CommonStockIssuedWithConvertibleNotes		usd
	NVOS	Warrants Issued With Convertible Notes WarrantsIssuedWithConvertibleNotes		usd
	NVOS	Other Receivable Write Offs OtherReceivableWriteOffs		usd
CY2023	NVOS	Other Receivable Write Offs OtherReceivableWriteOffs		usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2024Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves		usd
CY2023Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves		usd
CY2024Q1	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet		usd
CY2023Q3	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet		usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent		usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset		usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset		usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
CY2024Q1	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingIntrinsicValue		usd
CY2024Q1	NVOS	Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionExercisableIntrinsicValue1		usd
CY2024Q1	NVOS	Capital Expenditures CapitalExpenditures		usd
CY2023Q1	NVOS	Capital Expenditures CapitalExpenditures		usd
	NVOS	Capital Expenditures CapitalExpenditures		usd
	NVOS	Capital Expenditures CapitalExpenditures		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-02-29
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40089
	dei	Entity Registrant Name EntityRegistrantName	Novo Integrated Sciences, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	59-3691650
	dei	Entity Address Address Line1 EntityAddressAddressLine1	11120 NE 2nd Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100
	dei	Entity Address City Or Town EntityAddressCityOrTown	Bellevue
	dei	Entity Address State Or Province EntityAddressStateOrProvince	WA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	98004
	dei	City Area Code CityAreaCode	(206)
	dei	Local Phone Number LocalPhoneNumber	617-9797
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	NVOS
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	651747	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	416323	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2153914	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1467028	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	947351	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	1106983	usd
CY2024Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1048596	usd
CY2023Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1051584	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	217619	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	346171	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	5019227	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	4388089	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5246241	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5390038	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	15205967	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	16218539	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1916900	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1983898	usd
CY2024Q1	us-gaap	Goodwill Goodwill	7560936	usd
CY2023Q3	us-gaap	Goodwill Goodwill	7582483	usd
CY2024Q1	us-gaap	Assets Assets	34949271	usd
CY2023Q3	us-gaap	Assets Assets	35563047	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2173667	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	3513842	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1328828	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1233549	usd
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	477480	usd
CY2023Q3	us-gaap	Interest Payable Current InterestPayableCurrent	382666	usd
CY2024Q1	NVOS	Notes And Loan Payable Current NotesAndLoanPayableCurrent	93488	usd
CY2023Q3	NVOS	Notes And Loan Payable Current NotesAndLoanPayableCurrent	277405	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	2004245	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	2004245	usd
CY2024Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1773533	usd
CY2023Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	558668	usd
CY2024Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	2312921	usd
CY2024Q1	NVOS	Contingent Liabilities Current ContingentLiabilitiesCurrent	27756	usd
CY2023Q3	NVOS	Contingent Liabilities Current ContingentLiabilitiesCurrent	61767	usd
CY2024Q1	NVOS	Debentures Related Parties DebenturesRelatedParties	914219	usd
CY2023Q3	NVOS	Debentures Related Parties DebenturesRelatedParties	916824	usd
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	5788	usd
CY2023Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	11744	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	417342	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	415392	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	9959061	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	7904858	usd
CY2024Q1	NVOS	Long Term Notes And Loan LongTermNotesAndLoan	64016	usd
CY2023Q3	NVOS	Long Term Notes And Loan LongTermNotesAndLoan	65038	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1639391	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1693577	usd
CY2024Q1	us-gaap	Deferred Credits And Other Liabilities DeferredCreditsAndOtherLiabilities	1396519	usd
CY2023Q3	us-gaap	Deferred Credits And Other Liabilities DeferredCreditsAndOtherLiabilities	1400499	usd
CY2024Q1	us-gaap	Liabilities Liabilities	13058987	usd
CY2023Q3	us-gaap	Liabilities Liabilities	11063972	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	499000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	499000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15759325	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15759325	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	17749	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	15760	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	96082626	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	90973316	usd
CY2024Q1	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	17375	shares
CY2023Q3	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	91138	shares
CY2024Q1	NVOS	Common Stock Subscribed But Unissued Subscriptions Receivable CommonStockSubscribedButUnissuedSubscriptionsReceivable	44443	usd
CY2023Q3	NVOS	Common Stock Subscribed But Unissued Subscriptions Receivable CommonStockSubscribedButUnissuedSubscriptionsReceivable	1217293	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	503381	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-357383	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-74459512	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-67033041	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	22188687	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	24815945	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	-298403	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	-316870	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21890284	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24499075	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	34949271	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35563047	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3170592	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2556509	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7061810	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5975789	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	1846506	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	1585606	usd
	us-gaap	Cost Of Revenue CostOfRevenue	3793706	usd
	us-gaap	Cost Of Revenue CostOfRevenue	3265353	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	1324086	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	970903	usd
CY2024Q1	us-gaap	Selling Expense SellingExpense	2590	usd
CY2023Q1	us-gaap	Selling Expense SellingExpense	707	usd
	us-gaap	Selling Expense SellingExpense	12176	usd
	us-gaap	Selling Expense SellingExpense	8039	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2861264	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2757006	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8113333	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6731167	usd
	us-gaap	Operating Expenses OperatingExpenses	8125509	usd
	us-gaap	Operating Expenses OperatingExpenses	6739206	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1539768	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1786810	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4857405	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4028770	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	2477	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	2243	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	4696	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	4524	usd
CY2024Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	138684	usd
CY2023Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	123866	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	282058	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	291109	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-308763	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-960937	usd
CY2024Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	373339	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	958868	usd
CY2024Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1114573	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2740349	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2190501	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4230862	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-19588	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	3620	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-78946	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-35681	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1205792	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2858352	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2548878	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4553128	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2745560	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4645162	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7406283	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8581898	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-2745560	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-4645162	usd
	us-gaap	Profit Loss ProfitLoss	-7406283	usd
	us-gaap	Profit Loss ProfitLoss	-8581898	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	568	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-23807	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	20188	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-25130	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-2746128	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4621355	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7426471	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8556768	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-2745560	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-4645162	usd
	us-gaap	Profit Loss ProfitLoss	-7406283	usd
	us-gaap	Profit Loss ProfitLoss	-8581898	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	750067	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-196683	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	860764	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-617665	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1995493	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4841845	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6545519	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9199563	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5646937	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5646937	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.52
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.52
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24499075	usd
CY2023Q4	NVOS	Stock Issued During Period Value Cashless Exercise Of Warrants StockIssuedDuringPeriodValueCashlessExerciseOfWarrants	1323398	usd
CY2023Q4	NVOS	Stock Issued During Period Value Exercise Of Warrants For Cash StockIssuedDuringPeriodValueExerciseOfWarrantsForCash	240400	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	577522	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1195400	usd
CY2023Q4	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	108976	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	-4660723	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23284048	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	454073	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	750067	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	147656	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-2745560	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21890284	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	22047571	usd
CY2022Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1795000	usd
CY2022Q4	NVOS	Stock Issued During Period Value Cashless Exercise Of Warrants StockIssuedDuringPeriodValueCashlessExerciseOfWarrants	1139050	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	60887	usd
CY2022Q4	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	-420982	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-3936736	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	20684790	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	20684790	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	9086051	usd
CY2023Q1	NVOS	Stock Issued During Period Value Cashless Exercise Of Warrants StockIssuedDuringPeriodValueCashlessExerciseOfWarrants	282533	usd
CY2023Q1	NVOS	Stock Issued During Period Value Exercise Of Warrants For Cash StockIssuedDuringPeriodValueExerciseOfWarrantsForCash	131000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	82963	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	86327	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	60887	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	1390380	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	-196683	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-4645162	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26963086	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26963086	usd
	us-gaap	Profit Loss ProfitLoss	-7406283	usd
	us-gaap	Profit Loss ProfitLoss	-8581898	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1140613	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1138797	usd
	NVOS	Fair Value Of Vested Stock Options FairValueOfVestedStockOptions	-147656	usd
	NVOS	Fair Value Of Vested Stock Options FairValueOfVestedStockOptions	-121774	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	958868	usd
	NVOS	Cashless Exercise Of Warrants CashlessExerciseOfWarrants	1323398	usd
	NVOS	Cashless Exercise Of Warrants CashlessExerciseOfWarrants	1421583	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1195400	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	308867	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4230862	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	419256	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2190501	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-78946	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-35681	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	691424	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-57936	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-157116	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	78898	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-127885	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-6143	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1333031	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	299881	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	98987	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	148918	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	63151	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	28226	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-308867	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-405082	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3865953	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1156821	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-64837	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	6138	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	145	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	184475	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	5931	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	4299	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	3314153	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	445235	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	2977778	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1795000	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	240400	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	131000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3299455	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-604704	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	801922	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	192576	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	235424	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1568949	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	416323	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2178687	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	651747	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	609738	usd
	us-gaap	Interest Paid Net InterestPaidNet	158367	usd
	us-gaap	Interest Paid Net InterestPaidNet	275990	usd
	NVOS	Common Stock Issued For Convertible Debt Settlement CommonStockIssuedForConvertibleDebtSettlement	1031595	usd
	NVOS	Common Stock Issued For Convertible Debt Settlement CommonStockIssuedForConvertibleDebtSettlement	9086051	usd
	NVOS	Debt Discount Recognized On Derivative Liability DebtDiscountRecognizedOnDerivativeLiability	1390380	usd
	NVOS	Debt Discount Recognized On Convertible Note DebtDiscountRecognizedOnConvertibleNote	297055	usd
	NVOS	Extinguishment Of Derivative Liability Due To Conversions ExtinguishmentOfDerivativeLiabilityDueToConversions	1390380	usd
	NVOS	Common Stock Issued With Convertible Notes CommonStockIssuedWithConvertibleNotes	82963	usd
	NVOS	Warrants Issued With Convertible Notes WarrantsIssuedWithConvertibleNotes	86327	usd
CY2023Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-10 reverse stock split
CY2023Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-10 reverse stock split
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_ztV9kFjmzMIe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86E_z69muzV3p8vc">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. This applies in particular to the going concern assessment, useful lives of non-current assets, impairment of non-current assets, allowance for doubtful receivables, allowance for slow moving and obsolete inventory, valuation of share-based compensation and warrants, valuation of derivative liability, and valuation allowance for deferred tax assets. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
	NVOS	Schedule Of Intangible Assets Amortized Estimated Useful Lives ScheduleOfIntangibleAssetsAmortizedEstimatedUsefulLives	<p id="xdx_896_ecustom--ScheduleOfIntangibleAssetsAmortizedEstimatedUsefulLives_z1iZcjAjt4D5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s intangible assets are being amortized over their estimated useful lives as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zA0PA34dsyP1" style="display: none">Schedule of Intangible Assets Amortized Estimated Useful Lives</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Land use rights</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 73%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LandUseRightsMember_zcJJGjapUeLg" title="Intangible assets, estimated lives">50</span> years (the lease period)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual property</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zjkzI3y6U6Rc" title="Intangible assets, estimated lives">7</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer relationships</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zfKqZvBDmpgd" title="Intangible assets, estimated lives">5</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brand names</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zPLcRksLPXp7" title="Intangible assets, estimated lives">7</span> years</span></td></tr> </table>
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2024Q1	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P12M
CY2022Q3	us-gaap	Goodwill Goodwill	7825844	usd
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-243361	usd
CY2023Q3	us-gaap	Goodwill Goodwill	7582483	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-21547	usd
CY2024Q1	us-gaap	Goodwill Goodwill	7560936	usd
	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p id="xdx_849_eus-gaap--DerivativesReportingOfDerivativeActivity_zmXETspGNq72" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_z10ejQzikbJ4">Derivative Financial Instruments </span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value accounting requires bifurcation of embedded derivative instruments such as conversion features in convertible debt or equity instruments and measurement of their fair value for accounting purposes. In assessing the convertible debt instruments, management determines if the convertible debt host instrument is conventional convertible debt and further if there is a beneficial conversion feature requiring measurement. If the instrument is not considered conventional convertible debt under ASC 470, the Company will continue its evaluation process of these instruments as derivative financial instruments under ASC 815. The Company applies the guidance in ASC 815-40-35-12 to determine the order in which each convertible instrument would be evaluated for derivative classification.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once determined, derivative liabilities are adjusted to reflect fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to the fair value of derivatives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	integer
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_845_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zgI9vXF0AIa9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86C_zyQWWf2BbXja">Reclassifications </span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior period amounts were reclassified to conform to the manner of presentation in the current period. These reclassifications had no effect on the net loss or shareholders’ equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	NVOS	Trade Receivables TradeReceivables	2934906	usd
CY2023Q3	NVOS	Trade Receivables TradeReceivables	2223243	usd
CY2024Q1	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	66541	usd
CY2023Q3	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	108000	usd
CY2024Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3001447	usd
CY2023Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	2331243	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	847533	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	864215	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2153914	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1467028	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	500645	usd
CY2023Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	388391	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	225242	usd
CY2023Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	81696	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	221464	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	636896	usd
CY2024Q1	us-gaap	Inventory Gross InventoryGross	947351	usd
CY2023Q3	us-gaap	Inventory Gross InventoryGross	1106983	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	947351	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	1106983	usd
CY2024Q1	us-gaap	Inventory Adjustments InventoryAdjustments	1175306	usd
CY2024Q1	us-gaap	Other Receivables OtherReceivables	1048596	usd
CY2023Q3	us-gaap	Other Receivables OtherReceivables	1051584	usd
CY2024Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1048596	usd
CY2023Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1051584	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6624415	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6643247	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1378174	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1253209	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5246241	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5390038	usd
	us-gaap	Depreciation Depreciation	137919	usd
	us-gaap	Depreciation Depreciation	134123	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	23274451	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	23290546	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	8068484	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7072007	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	15205967	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16218539	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1002693	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1004674	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2004261	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1745101	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1441889	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1257489	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	236439	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	8520788	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	15205967	usd
CY2024Q1	NVOS	Accrued Liabilities Gross Current AccruedLiabilitiesGrossCurrent	943333	usd
CY2023Q3	NVOS	Accrued Liabilities Gross Current AccruedLiabilitiesGrossCurrent	961897	usd
CY2024Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	385495	usd
CY2023Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	236218	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	35434	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1328828	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1233549	usd
CY2024Q1	us-gaap	Notes And Loans Payable NotesAndLoansPayable	157504	usd
CY2023Q3	us-gaap	Notes And Loans Payable NotesAndLoansPayable	342443	usd
CY2024Q1	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	93488	usd
CY2023Q3	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	277405	usd
CY2024Q1	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	64016	usd
CY2023Q3	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	65038	usd
	NVOS	Debt Instrument Default Repayment Percentage DebtInstrumentDefaultRepaymentPercentage	0.75	pure
CY2024Q1	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.05	pure
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	93488	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	6469	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	6469	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	6469	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	6469	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	38140	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	157504	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1916900	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1983898	usd
CY2024Q1	NVOS	Operating Lease Assets OperatingLeaseAssets	1916900	usd
CY2023Q3	NVOS	Operating Lease Assets OperatingLeaseAssets	1983898	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	417342	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	415392	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1639391	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1693577	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2056733	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2108969	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	579401	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	534994	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	550749	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	393723	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	240903	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	239381	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2539151	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	482418	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2056733	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	417342	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1639391	usd
	us-gaap	Payments For Rent PaymentsForRent	308867	usd
	us-gaap	Payments For Rent PaymentsForRent	419256	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	293729	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	405082	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y10M20D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0868	pure
CY2024Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.05	pure
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	209457	usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	209457	usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	209457	usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	209457	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	5854	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	5854	usd
CY2024Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	66	usd
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	5788	usd
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	5788	usd
CY2023Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-10 reverse stock split
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	499000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	499000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17748320	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17748320	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15759325	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15759325	shares
CY2023Q4	us-gaap	Stock Issued During Period Shares Reverse Stock Splits StockIssuedDuringPeriodSharesReverseStockSplits	27973	shares
CY2023Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-10 reverse stock split
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	371423	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.44
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y11M23D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	16000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	200000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.78
	NVOS	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2	P5Y10M17D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	10500	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	17.62
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	560923	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.52
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y8M12D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	560923	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.52
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y8M12D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	560923	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	560923	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	200000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation ShareBasedCompensation	147656	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	121774	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	806254	shares
CY2023Q3	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageExercisePrice	12.05
CY2023	NVOS	Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionOutstandingWeightedAverageRemainingContractualTerm2	P3Y8M15D
CY2023Q3	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingIntrinsicValue	106960	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	518061	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	288193	shares
CY2024Q1	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageExercisePrice	30.46
	NVOS	Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionOutstandingWeightedAverageRemainingContractualTerm2	P3Y2M15D
CY2024Q1	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionExercisableNumber	288193	shares
CY2024Q1	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionExercisableWeightedAverageExercisePrice	30.46
	NVOS	Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionExercisableWeightedAverageRemainingContractualTerm1	P3Y2M15D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	288193	shares
	us-gaap	Other Expenses OtherExpenses	652174	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3170592	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2556509	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7061810	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5975789	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	1324086	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	970903	usd
	us-gaap	Gross Profit GrossProfit	3268104	usd
	us-gaap	Gross Profit GrossProfit	2710436	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1539768	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1786810	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4857405	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4028770	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	568209	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	552631	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1140613	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1138797	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	138684	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	123866	usd
	us-gaap	Interest Expense InterestExpense	282058	usd
	us-gaap	Interest Expense InterestExpense	291109	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-2745560	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-4645162	usd
	us-gaap	Profit Loss ProfitLoss	-7406283	usd
	us-gaap	Profit Loss ProfitLoss	-8581898	usd
CY2024Q1	us-gaap	Assets Assets	34949271	usd
CY2023Q3	us-gaap	Assets Assets	35563047	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2153914	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1467028	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	15205967	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16218539	usd
CY2024Q1	us-gaap	Goodwill Goodwill	7560936	usd
CY2023Q3	us-gaap	Goodwill Goodwill	7582483	usd
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001493152-24-014632-index-headers.html	Edgar Link	pending
0001493152-24-014632-index.html	Edgar Link	pending
0001493152-24-014632.txt	Edgar Link	pending
0001493152-24-014632-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nvos-20240229.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
nvos-20240229_cal.xml	Edgar Link	unprocessable
nvos-20240229_def.xml	Edgar Link	unprocessable
nvos-20240229_lab.xml	Edgar Link	unprocessable
nvos-20240229_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NVOS
Novo Integrated Sciences, Inc. Stock $nvos

2024 Q2 Form 10-Q Financial Statement

#000149315224014632 Filed on April 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVOS Novo Integrated Sciences, Inc. Stock $nvos

2024 Q2 Form 10-Q Financial Statement

#000149315224014632 Filed on April 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVOS
Novo Integrated Sciences, Inc. Stock $nvos